Clinical Trial

LVT DURATION: Pilot Study of Anticoagulation Duration for Left Ventricular Thrombus

Study acronym: LVT Duration
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The LVT DURATION (Optimal Duration of Anticoagulation for LV Thrombus) is a pilot study planned to assess the practicalities of conducting a randomised control trial (RCT) whilst establishing data around the ideal duration of anticoagulation in the treatment of LV thrombus. The main objectives of the study are: * To assess the practicalities of conducting an RCT with regard to recruitment, retention, and outcome measurement. * To identify the optimal length of anticoagulation in the treatment of LV Thrombus After randomisation participants will: * Continue their prescribed oral anticoagulant for the remainder of the trial * Discontinue their prescribed oral anticoagulant for the remainder of the trial
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-17.
Trial Details
NCT Number NCT07246005
Lead Sponsor Queen Mary University of London
Conditions Left Ventricular Thrombus
Enrollment 120 participants
Start Date 2026-12-01
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27